Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

biogen_idec_hillerod_2008

Biogen halts Tysabri trial after failure in acute ischemic stroke

February 8, 2018 Research and Development Biogen, Tysabri, multiple sclerosis, pharma, stroke, trial failure

Biogen has halted its investigation into the efficacy of its humanised monoclonal antibody Tysabri (natalizumab) in the treatment of acute …
News
kenji

Astellas confirms Kenji Yasukawa as new President and CEO

February 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, appointment

Japanese pharmaceutical firm Astellas has announced that its Board of Directors has approved the selection of current Chief Strategy Officer …
Appointment
arcturus_joseph-e-payne

CEO gets the axe: Arcturus relieve Payne of position

February 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arcturus, biotech, drugs, pharma, pharmaceutical

Early in February, Arcturus Therapeutics revealed that it had let its CEO, Joseph Payne, go and had replaced him as …
Appointment

J&J’s apalutamide shows strength in non-metastatic prostate cancer

February 7, 2018 Research and Development J&J, JJ, Johnson & Johnson, pharma, prostate cancer

Johnson & Johnson unveiled new data at the ASCO Genitourinary Cancer symposium which demonstrated that its androgen receptor antagonist apalutamide …
News
array_biopharma

Array’s melanoma therapy blasts Roche’s out of water

February 7, 2018 Research and Development Array Biopharma, Pierre Fabre, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

Array Biopharma suffered a serious knock back in early 2017 when its plan to commercialise its drug, binimetinib, were derailed …
News
allergan

Allergan bolsters skincare portfolio with Elastagen acquisition for $95 million

February 7, 2018 Research and Development, Sales and Marketing Allergan, Elastagen, M&A, MA, pharma

Pharma’s M&A train keeps on going as news breaks that Allergan has picked up University of Sydney spin-off Elastagen for …
News
flu

NHS tells doctors to order stronger vaccine for next winter

February 7, 2018 Medical Communications, Research and Development NHS, biotech, drugs, flu season, pharma, pharmaceutical

England is not alone in being particularly hard hit this flu season, with Australia suffering its worst flu season in …
News
allergan-westport-ireland_web

New breakthrough for CGRP migraine treatments

February 6, 2018 Research and Development Allergan, Amgen, CGRP, Novartis, biotech, drugs, pharma, pharmaceutical

Allergan had a rough year in 2017, dropping by close to $80 a share from February 2017 to this month. …
News
mark_walsh_allergan

Allergan successfully concludes CFO search

February 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

Allergan has been searching for a new Chief Financial Officer since Tessa Hilado, its current CFO, revealed that she would …
Appointment
450px-papilloma_virus_hpv

UK Government to offer HPV vaccine to men who have sex with men

February 6, 2018 Manufacturing and Production, Medical Communications, Research and Development England, HPV, UK, human papillomavirus, pharma, vaccination

The UK Government has confirmed a national vaccination programme that will provide access for men who have sex with men(MSM) …
News

BMS’ Opdivo and Yervoy combo better than chemo in halting lung cancer progression

February 6, 2018 Manufacturing and Production, Research and Development BMS, Bristol-Myers Squibb, NSCLC, Yervoy, lung cancer, opdivo, pharma

Bristol-Myers Squibb has revealed promising data from its ongoing Phase 3 study investigating the efficacy of Opdivo (nivolumab) in combination …
News
abbottweb

Abbott teams up with Angle for metastatic breast cancer study

February 6, 2018 Manufacturing and Production, Research and Development Abbott, Angle, Cancer, breast cancer, pharma

Abbott is set to join forces with liquid biopsy medtech firm Angle to collaborate on a study into metastatic breast …
News
ai_graphic

The future is now: The transformative power of AI

February 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Exscientia, GSK, GlaxoSmithKline, artificial intelligence, drug development, pharma

With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be …
Feature
pink_ribbon

UK breast cancer mortality falls 10% over five years, overtaken by prostate deaths for first time

February 5, 2018 Research and Development, Sales and Marketing Cancer, Cancer Research UK, breast cancer, pharma, prostate cancer

Breast cancer deaths in the UK have fallen by 10% in the past five years, according to research released by …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 2, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Alzheimer's, Apotex, AstraZeneca, Brexit Health Alliance, CDC, Duchenne Muscular Dystrophy, EMA, Italy, Sanofi, amazon, brexit, santhera, top ten

It’s the first Friday of February, and it’s time for another recap of the top ten articles most popular with …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025